APO Research
Talk to an analyst

APO RESEARCH · REPORT

Solid Tumors Target Proteins

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Solid Tumors Target Proteins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025191 pages

Choose your research edition.

Industry ResearchSolid Tumors Target Proteins Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Solid Tumors Target Proteins Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Solid Tumors Target Proteins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Solid Tumors Target Proteins Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Solid Tumors Target Proteins Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Solid Tumors Target Proteins market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Solid Tumors Target Proteins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Solid Tumors Target Proteins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Solid Tumors Target Proteins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Solid Tumors Target Proteins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Solid Tumors Target Proteins include Novartis, Sino Biological, ACRO Biosystems, TargetMol Chemicals, ProteoGenix, Kite Pharma, Kactus Biosystems, Juno Therapeutics and Elabscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Solid Tumors Target Proteins market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Solid Tumors Target Proteins and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Solid Tumors Target Proteins revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Solid Tumors Target Proteins market size, projected growth trends, production technologies, key applications, and end-use industries.

Solid Tumors Target Proteins Segment by Company

Novartis

Sino Biological

ACRO Biosystems

TargetMol Chemicals

ProteoGenix

Kite Pharma

Kactus Biosystems

Juno Therapeutics

Elabscience

Creative BioMart

Creative Biolabs

Bio-Techne

Bio X Cell

ACROBiosystems

Solid Tumors Target Proteins Segment by Type

EGFR Protein

HER2 Protein

Others

Solid Tumors Target Proteins Segment by Application

Hospital

Biological Laboratory

Others

Solid Tumors Target Proteins Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Solid Tumors Target Proteins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Solid Tumors Target Proteins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Solid Tumors Target Proteins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Solid Tumors Target Proteins in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Solid Tumors Target Proteins industry.

Chapter 3: Detailed analysis of Solid Tumors Target Proteins companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Solid Tumors Target Proteinsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Solid Tumors Target Proteins Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of EGFR Protein Table 3. Key Players of HER2 Protein Table 4. Key Players of Others Table 4. Global Solid Tumors Target Proteins Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Biological Laboratory Table 7. Key Players of Others Table 8. Global Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Solid Tumors Target Proteins Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Solid Tumors Target Proteins Market Share by Region (2021-2026) Table 11. Global Solid Tumors Target Proteins Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Solid Tumors Target Proteins Market Share by Region (2027-2032) Table 13. Solid Tumors Target Proteins Industry Trends Table 14. Solid Tumors Target Proteins Industry Drivers Table 15. Solid Tumors Target Proteins Industry Opportunities and Challenges Table 16. Solid Tumors Target Proteins Industry Restraints Table 17. Global Solid Tumors Target Proteins Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Solid Tumors Target Proteins Revenue Market Share by Company (2021-2026) Table 19. Global Solid Tumors Target Proteins Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Solid Tumors Target Proteins Key Company Head Office and Area Served Table 21. Global Solid Tumors Target Proteins Company, Product Type & Application Table 22. Global Solid Tumors Target Proteins Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Solid Tumors Target Proteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Solid Tumors Target Proteins Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Solid Tumors Target Proteins Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Solid Tumors Target Proteins Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Solid Tumors Target Proteins Revenue Market Share by Type (2021-2026) Table 29. Global Solid Tumors Target Proteins Revenue Market Share by Type (2027-2032) Table 30. Global Solid Tumors Target Proteins Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Solid Tumors Target Proteins Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Solid Tumors Target Proteins Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Solid Tumors Target Proteins Revenue Market Share by Application (2021-2026) Table 34. Global Solid Tumors Target Proteins Revenue Market Share by Application (2027-2032) Table 35. Novartis Company Information Table 36. Novartis Business Overview Table 37. Novartis Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Novartis Solid Tumors Target Proteins Product Portfolio Table 39. Novartis Recent Development Table 40. Sino Biological Company Information Table 41. Sino Biological Business Overview Table 42. Sino Biological Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sino Biological Solid Tumors Target Proteins Product Portfolio Table 44. Sino Biological Recent Development Table 45. ACRO Biosystems Company Information Table 46. ACRO Biosystems Business Overview Table 47. ACRO Biosystems Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. ACRO Biosystems Solid Tumors Target Proteins Product Portfolio Table 49. ACRO Biosystems Recent Development Table 50. TargetMol Chemicals Company Information Table 51. TargetMol Chemicals Business Overview Table 52. TargetMol Chemicals Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. TargetMol Chemicals Solid Tumors Target Proteins Product Portfolio Table 54. TargetMol Chemicals Recent Development Table 55. ProteoGenix Company Information Table 56. ProteoGenix Business Overview Table 57. ProteoGenix Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. ProteoGenix Solid Tumors Target Proteins Product Portfolio Table 59. ProteoGenix Recent Development Table 60. Kite Pharma Company Information Table 61. Kite Pharma Business Overview Table 62. Kite Pharma Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Kite Pharma Solid Tumors Target Proteins Product Portfolio Table 64. Kite Pharma Recent Development Table 65. Kactus Biosystems Company Information Table 66. Kactus Biosystems Business Overview Table 67. Kactus Biosystems Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Kactus Biosystems Solid Tumors Target Proteins Product Portfolio Table 69. Kactus Biosystems Recent Development Table 70. Juno Therapeutics Company Information Table 71. Juno Therapeutics Business Overview Table 72. Juno Therapeutics Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Juno Therapeutics Solid Tumors Target Proteins Product Portfolio Table 74. Juno Therapeutics Recent Development Table 75. Elabscience Company Information Table 76. Elabscience Business Overview Table 77. Elabscience Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Elabscience Solid Tumors Target Proteins Product Portfolio Table 79. Elabscience Recent Development Table 80. Creative BioMart Company Information Table 81. Creative BioMart Business Overview Table 82. Creative BioMart Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Creative BioMart Solid Tumors Target Proteins Product Portfolio Table 84. Creative BioMart Recent Development Table 85. Creative Biolabs Company Information Table 86. Creative Biolabs Business Overview Table 87. Creative Biolabs Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Creative Biolabs Solid Tumors Target Proteins Product Portfolio Table 89. Creative Biolabs Recent Development Table 90. Bio-Techne Company Information Table 91. Bio-Techne Business Overview Table 92. Bio-Techne Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Bio-Techne Solid Tumors Target Proteins Product Portfolio Table 94. Bio-Techne Recent Development Table 95. Bio X Cell Company Information Table 96. Bio X Cell Business Overview Table 97. Bio X Cell Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Bio X Cell Solid Tumors Target Proteins Product Portfolio Table 99. Bio X Cell Recent Development Table 100. ACROBiosystems Company Information Table 101. ACROBiosystems Business Overview Table 102. ACROBiosystems Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. ACROBiosystems Solid Tumors Target Proteins Product Portfolio Table 104. ACROBiosystems Recent Development Table 105. North America Solid Tumors Target Proteins Market Size by Type (2021-2026) & (US$ Million) Table 106. North America Solid Tumors Target Proteins Market Size by Type (2027-2032) & (US$ Million) Table 107. North America Solid Tumors Target Proteins Market Size by Application (2021-2026) & (US$ Million) Table 108. North America Solid Tumors Target Proteins Market Size by Application (2027-2032) & (US$ Million) Table 109. North America Solid Tumors Target Proteins Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Solid Tumors Target Proteins Market Size by Country (2021-2026) Table 111. North America Solid Tumors Target Proteins Market Size by Country (2027-2032) Table 112. Europe Solid Tumors Target Proteins Market Size by Type (2021-2026) & (US$ Million) Table 113. Europe Solid Tumors Target Proteins Market Size by Type (2027-2032) & (US$ Million) Table 114. Europe Solid Tumors Target Proteins Market Size by Application (2021-2026) & (US$ Million) Table 115. Europe Solid Tumors Target Proteins Market Size by Application (2027-2032) & (US$ Million) Table 116. Europe Solid Tumors Target Proteins Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Solid Tumors Target Proteins Market Size by Country (2021-2026) Table 118. Europe Solid Tumors Target Proteins Market Size by Country (2027-2032) Table 119. China Solid Tumors Target Proteins Market Size by Type (2021-2026) & (US$ Million) Table 120. China Solid Tumors Target Proteins Market Size by Type (2027-2032) & (US$ Million) Table 121. China Solid Tumors Target Proteins Market Size by Application (2021-2026) & (US$ Million) Table 122. China Solid Tumors Target Proteins Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia Solid Tumors Target Proteins Market Size by Type (2021-2026) & (US$ Million) Table 124. Asia Solid Tumors Target Proteins Market Size by Type (2027-2032) & (US$ Million) Table 125. Asia Solid Tumors Target Proteins Market Size by Application (2021-2026) & (US$ Million) Table 126. Asia Solid Tumors Target Proteins Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia Solid Tumors Target Proteins Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Solid Tumors Target Proteins Market Size by Country (2021-2026) Table 129. Asia Solid Tumors Target Proteins Market Size by Country (2027-2032) Table 130. South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Type (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Type (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Application (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Application (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2021-2026) Table 136. South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Solid Tumors Target Proteins Product Image Figure 2. Global Solid Tumors Target Proteins Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Solid Tumors Target Proteins Market Share by Type: 2025 VS 2032 Figure 4. EGFR Protein Image Figure 5. HER2 Protein Image Figure 6. Others Image Figure 7. Global Solid Tumors Target Proteins Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Solid Tumors Target Proteins Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Biological Laboratory Image Figure 11. Others Image Figure 12. Global Solid Tumors Target Proteins Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 14. Global Solid Tumors Target Proteins Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Solid Tumors Target Proteins Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Solid Tumors Target Proteins Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Solid Tumors Target Proteins Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Solid Tumors Target Proteins Revenue Market Share by Type (2021-2032) Figure 21. Global Solid Tumors Target Proteins Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Solid Tumors Target Proteins Revenue Market Share by Application (2021-2032) Figure 23. North America Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 24. North America Solid Tumors Target Proteins Market Share by Type (2021-2032) Figure 25. North America Solid Tumors Target Proteins Market Share by Application (2021-2032) Figure 26. North America Solid Tumors Target Proteins Market Share by Country (2021-2032) Figure 27. United States Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 28. Canada Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 30. Europe Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 31. Europe Solid Tumors Target Proteins Market Share by Type (2021-2032) Figure 32. Europe Solid Tumors Target Proteins Market Share by Application (2021-2032) Figure 33. Europe Solid Tumors Target Proteins Market Share by Country (2021-2032) Figure 34. Germany Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 35. France Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 37. Italy Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 38. Russia Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 40. China Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 41. China Solid Tumors Target Proteins Market Share by Type (2021-2032) Figure 42. China Solid Tumors Target Proteins Market Share by Application (2021-2032) Figure 43. Asia Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 44. Asia Solid Tumors Target Proteins Market Share by Type (2021-2032) Figure 45. Asia Solid Tumors Target Proteins Market Share by Application (2021-2032) Figure 46. Asia Solid Tumors Target Proteins Market Share by Country (2021-2032) Figure 47. Japan Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 51. India Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 52. Australia Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Solid Tumors Target Proteins Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Solid Tumors Target Proteins Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Solid Tumors Target Proteins Market Share by Country (2021-2032) Figure 57. Brazil Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 62. UAE Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 64. Chile Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • EGFR Protein
  • HER2 Protein
  • Others
Applications
  • Hospital
  • Biological Laboratory
  • Others
Companies covered
  • Novartis
  • Sino Biological
  • ACRO Biosystems
  • TargetMol Chemicals
  • ProteoGenix
  • Kite Pharma
  • Kactus Biosystems
  • Juno Therapeutics
  • Elabscience
  • Creative BioMart
  • Creative Biolabs
  • Bio-Techne
  • Bio X Cell
  • ACROBiosystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Solid Tumors Target Proteins Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 EGFR Protein
  5. 1.2.3 HER2 Protein
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Solid Tumors Target Proteins Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Biological Laboratory
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Solid Tumors Target Proteins Growth Trends by Region
  14. 1.5.1 Global Solid Tumors Target Proteins Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Solid Tumors Target Proteins Market Size by Region (2021-2026)
  16. 1.5.3 Solid Tumors Target Proteins Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Solid Tumors Target Proteins Market Dynamics
  1. 2.1 Solid Tumors Target Proteins Industry Trends
  2. 2.2 Solid Tumors Target Proteins Industry Drivers
  3. 2.3 Solid Tumors Target Proteins Industry Opportunities and Challenges
  4. 2.4 Solid Tumors Target Proteins Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Solid Tumors Target Proteins Revenue by Company (2021-2026)
  2. 3.2 Global Solid Tumors Target Proteins Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Solid Tumors Target Proteins Key Company Head office and Area Served
  4. 3.4 Global Solid Tumors Target Proteins Company, Product Type & Application
  5. 3.5 Global Solid Tumors Target Proteins Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Solid Tumors Target Proteins Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Solid Tumors Target Proteins Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Solid Tumors Target Proteins Tier 1, Tier 2, and Tier 3
4 Solid Tumors Target Proteins Market by Type
  1. 4.1 Global Solid Tumors Target Proteins Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Solid Tumors Target Proteins Market Size by Type (2021-2032)
  3. 4.3 Global Solid Tumors Target Proteins Market Size Share by Type (2021-2032)
5 Solid Tumors Target Proteins Market by Application
  1. 5.1 Global Solid Tumors Target Proteins Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Solid Tumors Target Proteins Market Size by Application (2021-2032)
  3. 5.3 Global Solid Tumors Target Proteins Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Solid Tumors Target Proteins Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Sino Biological
  8. 6.2.1 Sino Biological Company Information
  9. 6.2.2 Sino Biological Business Overview
  10. 6.2.3 Sino Biological Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sino Biological Solid Tumors Target Proteins Product Portfolio
  12. 6.2.5 Sino Biological Recent Developments
  13. 6.3 ACRO Biosystems
  14. 6.3.1 ACRO Biosystems Company Information
  15. 6.3.2 ACRO Biosystems Business Overview
  16. 6.3.3 ACRO Biosystems Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 ACRO Biosystems Solid Tumors Target Proteins Product Portfolio
  18. 6.3.5 ACRO Biosystems Recent Developments
  19. 6.4 TargetMol Chemicals
  20. 6.4.1 TargetMol Chemicals Company Information
  21. 6.4.2 TargetMol Chemicals Business Overview
  22. 6.4.3 TargetMol Chemicals Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 TargetMol Chemicals Solid Tumors Target Proteins Product Portfolio
  24. 6.4.5 TargetMol Chemicals Recent Developments
  25. 6.5 ProteoGenix
  26. 6.5.1 ProteoGenix Company Information
  27. 6.5.2 ProteoGenix Business Overview
  28. 6.5.3 ProteoGenix Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 ProteoGenix Solid Tumors Target Proteins Product Portfolio
  30. 6.5.5 ProteoGenix Recent Developments
  31. 6.6 Kite Pharma
  32. 6.6.1 Kite Pharma Company Information
  33. 6.6.2 Kite Pharma Business Overview
  34. 6.6.3 Kite Pharma Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Kite Pharma Solid Tumors Target Proteins Product Portfolio
  36. 6.6.5 Kite Pharma Recent Developments
  37. 6.7 Kactus Biosystems
  38. 6.7.1 Kactus Biosystems Company Information
  39. 6.7.2 Kactus Biosystems Business Overview
  40. 6.7.3 Kactus Biosystems Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Kactus Biosystems Solid Tumors Target Proteins Product Portfolio
  42. 6.7.5 Kactus Biosystems Recent Developments
  43. 6.8 Juno Therapeutics
  44. 6.8.1 Juno Therapeutics Company Information
  45. 6.8.2 Juno Therapeutics Business Overview
  46. 6.8.3 Juno Therapeutics Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Juno Therapeutics Solid Tumors Target Proteins Product Portfolio
  48. 6.8.5 Juno Therapeutics Recent Developments
  49. 6.9 Elabscience
  50. 6.9.1 Elabscience Company Information
  51. 6.9.2 Elabscience Business Overview
  52. 6.9.3 Elabscience Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Elabscience Solid Tumors Target Proteins Product Portfolio
  54. 6.9.5 Elabscience Recent Developments
  55. 6.10 Creative BioMart
  56. 6.10.1 Creative BioMart Company Information
  57. 6.10.2 Creative BioMart Business Overview
  58. 6.10.3 Creative BioMart Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Creative BioMart Solid Tumors Target Proteins Product Portfolio
  60. 6.10.5 Creative BioMart Recent Developments
  61. 6.11 Creative Biolabs
  62. 6.11.1 Creative Biolabs Company Information
  63. 6.11.2 Creative Biolabs Business Overview
  64. 6.11.3 Creative Biolabs Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Creative Biolabs Solid Tumors Target Proteins Product Portfolio
  66. 6.11.5 Creative Biolabs Recent Developments
  67. 6.12 Bio-Techne
  68. 6.12.1 Bio-Techne Company Information
  69. 6.12.2 Bio-Techne Business Overview
  70. 6.12.3 Bio-Techne Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Bio-Techne Solid Tumors Target Proteins Product Portfolio
  72. 6.12.5 Bio-Techne Recent Developments
  73. 6.13 Bio X Cell
  74. 6.13.1 Bio X Cell Company Information
  75. 6.13.2 Bio X Cell Business Overview
  76. 6.13.3 Bio X Cell Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Bio X Cell Solid Tumors Target Proteins Product Portfolio
  78. 6.13.5 Bio X Cell Recent Developments
  79. 6.14 ACROBiosystems
  80. 6.14.1 ACROBiosystems Company Information
  81. 6.14.2 ACROBiosystems Business Overview
  82. 6.14.3 ACROBiosystems Solid Tumors Target Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 ACROBiosystems Solid Tumors Target Proteins Product Portfolio
  84. 6.14.5 ACROBiosystems Recent Developments
7 North America
  1. 7.1 North America Solid Tumors Target Proteins Market Size (2021-2032)
  2. 7.2 North America Solid Tumors Target Proteins Market Size by Type
  3. 7.2.1 North America Solid Tumors Target Proteins Market Size by Type (2021-2026)
  4. 7.2.2 North America Solid Tumors Target Proteins Market Size by Type (2027-2032)
  5. 7.2.3 North America Solid Tumors Target Proteins Market Share by Type (2021-2032)
  6. 7.3 North America Solid Tumors Target Proteins Market Size by Application
  7. 7.3.1 North America Solid Tumors Target Proteins Market Size by Application (2021-2026)
  8. 7.3.2 North America Solid Tumors Target Proteins Market Size by Application (2027-2032)
  9. 7.3.3 North America Solid Tumors Target Proteins Market Share by Application (2021-2032)
  10. 7.4 North America Solid Tumors Target Proteins Market Size by Country
  11. 7.4.1 North America Solid Tumors Target Proteins Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Solid Tumors Target Proteins Market Size by Country (2021-2026)
  13. 7.4.3 North America Solid Tumors Target Proteins Market Size by Country (2027-2032)
  14. 7.4.4 North America Solid Tumors Target Proteins Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Solid Tumors Target Proteins Market Size (2021-2032)
  2. 8.2 Europe Solid Tumors Target Proteins Market Size by Type
  3. 8.2.1 Europe Solid Tumors Target Proteins Market Size by Type (2021-2026)
  4. 8.2.2 Europe Solid Tumors Target Proteins Market Size by Type (2027-2032)
  5. 8.2.3 Europe Solid Tumors Target Proteins Market Share by Type (2021-2032)
  6. 8.3 Europe Solid Tumors Target Proteins Market Size by Application
  7. 8.3.1 Europe Solid Tumors Target Proteins Market Size by Application (2021-2026)
  8. 8.3.2 Europe Solid Tumors Target Proteins Market Size by Application (2027-2032)
  9. 8.3.3 Europe Solid Tumors Target Proteins Market Share by Application (2021-2032)
  10. 8.4 Europe Solid Tumors Target Proteins Market Size by Country
  11. 8.4.1 Europe Solid Tumors Target Proteins Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Solid Tumors Target Proteins Market Size by Country (2021-2026)
  13. 8.4.3 Europe Solid Tumors Target Proteins Market Size by Country (2027-2032)
  14. 8.4.4 Europe Solid Tumors Target Proteins Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Solid Tumors Target Proteins Market Size (2021-2032)
  2. 9.2 China Solid Tumors Target Proteins Market Size by Type
  3. 9.2.1 China Solid Tumors Target Proteins Market Size by Type (2021-2026)
  4. 9.2.2 China Solid Tumors Target Proteins Market Size by Type (2027-2032)
  5. 9.2.3 China Solid Tumors Target Proteins Market Share by Type (2021-2032)
  6. 9.3 China Solid Tumors Target Proteins Market Size by Application
  7. 9.3.1 China Solid Tumors Target Proteins Market Size by Application (2021-2026)
  8. 9.3.2 China Solid Tumors Target Proteins Market Size by Application (2027-2032)
  9. 9.3.3 China Solid Tumors Target Proteins Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Solid Tumors Target Proteins Market Size (2021-2032)
  2. 10.2 Asia Solid Tumors Target Proteins Market Size by Type
  3. 10.2.1 Asia Solid Tumors Target Proteins Market Size by Type (2021-2026)
  4. 10.2.2 Asia Solid Tumors Target Proteins Market Size by Type (2027-2032)
  5. 10.2.3 Asia Solid Tumors Target Proteins Market Share by Type (2021-2032)
  6. 10.3 Asia Solid Tumors Target Proteins Market Size by Application
  7. 10.3.1 Asia Solid Tumors Target Proteins Market Size by Application (2021-2026)
  8. 10.3.2 Asia Solid Tumors Target Proteins Market Size by Application (2027-2032)
  9. 10.3.3 Asia Solid Tumors Target Proteins Market Share by Application (2021-2032)
  10. 10.4 Asia Solid Tumors Target Proteins Market Size by Country
  11. 10.4.1 Asia Solid Tumors Target Proteins Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Solid Tumors Target Proteins Market Size by Country (2021-2026)
  13. 10.4.3 Asia Solid Tumors Target Proteins Market Size by Country (2027-2032)
  14. 10.4.4 Asia Solid Tumors Target Proteins Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Solid Tumors Target Proteins Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Solid Tumors Target Proteins Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Solid Tumors Target Proteins Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Solid Tumors Target Proteins Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst